ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1540

Comparison of Radiologic Parameters of Ankylosing Spondylitis Treated with Anti-TNF-α Versus Non-Steroidal Anti-Inflammatory Drugs and Sulfasalazine

Seung Min Son, Orthopaedic surgery, Pusan National University Yangsan Hospital, Yangsan, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Ankylosing spondylitis (AS), radiography and tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

There are many studies about impact of TNF-inhibitors on radiographic progression but little data are available on the relationship between treatment agents and sagittal balance in AS. We focus on radiological aspects related to treatment agents and compare sagittal balance treated with anti-TNF-α to non-steroidal anti-inflammatory drugs and sulfasalazine.

Methods:

One hundred thirty three consecutive AS patients were enrolled prospectively. AS patients were eligible to participate in the trial if they were in medical treatment with same treatment agents at least from 1 year. All patients were treated with NSAIDs and sulfasalazine first. 69 patients were showed excellent outcome of pain control with same agents (Group A). But 64 patients complained of intractable low back pain even though treated with same agents. After at least 3 months, we changed treatment agents for these patients to anti-TNF-α therapy (Group B). Radiographic parameters, that is, sacral slope (SS), pelvic tilt (PT), pelvic incidence (PI), thoracic kyphosis (TK), lumbar lordosis (LL), horizontal distance between C7 plumb line and the posterosuperior corner of the sacrum (C7PL), sacrofemoral distance (SFD), C7PL/SFD ratio (C7/SFD), spinosacral angle (SSA), spinopelvic angle (SPA), C2-C7 lordosis (CL), C2-C7 sagittal vertical axis (C2-C7 SVA) were measured. For the assessment of clinical outcome, the Bath AS Disease Activity Index (BASDAI) score and erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level were checked. Radiologic and clinical parameters were checked at enrolment, when changing treatment agents and every 6 months during the follow-up period.

Results:

Significantly differences were observed at baseline between two groups. Mean ESR, CRP, and BASDAI were significantly higher in group B. Patients in group B had significantly higher TK compared with group A. In comparison between both groups after treatment, patients in group B had significantly higher lumbar lordosis after treatment. And clinical outcomes including ESR, CRP, BASDAI were significantly lower in group B. At the comparisons between before and after treatment in both groups, there was no significant difference among radiologic parameters in group A. Only BASDAI score had lower after treatment in group A. But in group B, lumbar lordosis and cervical lordosis were significantly increased after treatment. And ESR, CRP, and BASDAI were significantly lower than before treatment. Correlation analysis revealed significant relationships between radiologic parameters and BASDAI. Under multiple regression analysis, lumbar lordosis was the significant predictor for BASDAI.

Conclusion:

This study shows a clear association between treatment agents and radiologic parameters in AS. Furthermore, patients in group B and patients in group A were found to be significantly different in terms of sagittal radiologic parameters like thoracic kyphosis and lumbar lordosis. In addition, correlation analysis revealed significant relationships between radiologic parameters and clinical outcomes. Anti-TNF-α treatment improved lumbar lordosis and made slow thoracic kyphotic progression with improvement of clinical outcomes in AS.


Disclosure: S. M. Son, None;

To cite this abstract in AMA style:

Son SM. Comparison of Radiologic Parameters of Ankylosing Spondylitis Treated with Anti-TNF-α Versus Non-Steroidal Anti-Inflammatory Drugs and Sulfasalazine [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/comparison-of-radiologic-parameters-of-ankylosing-spondylitis-treated-with-anti-tnf-%ce%b1-versus-non-steroidal-anti-inflammatory-drugs-and-sulfasalazine/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-radiologic-parameters-of-ankylosing-spondylitis-treated-with-anti-tnf-%ce%b1-versus-non-steroidal-anti-inflammatory-drugs-and-sulfasalazine/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology